19 Jun 2014 --- Kappa Bioscience AS, Oslo, Norway, is pleased to announce that today we have obtained Therapeutic Goods Australia (TGA) approval on the use of synthetic Vitamin K2 MK-7 in complementary medicine for Australian use.
